{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:55:15Z","timestamp":1778158515627,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":45,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.radonc.2013.04.008","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T09:52:51Z","timestamp":1367574771000},"page":"428-433","source":"Crossref","is-referenced-by-count":37,"title":["Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial"],"prefix":"10.1016","volume":"107","author":[{"given":"Cecilie Delphin","family":"Amdal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Birgitte","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berit","family":"Sandstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trond","family":"Warloe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Bjordal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2013.04.008_b0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2036.2007.03589.x","article-title":"Factors predicting survival in patients with advanced oesophageal cancer: a prospective multicentre evaluation","volume":"27","author":"Bergquist","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.radonc.2013.04.008_b0010","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.ijrobp.2003.09.100","article-title":"Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy","volume":"58","author":"Fang","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.04.008_b0015","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1442-2050.2010.01174.x","article-title":"Palliative interventions and prognosis in patients with advanced esophageal cancer","volume":"24","author":"Amdal","year":"2011","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.radonc.2013.04.008_b0020","first-page":"A4459","article-title":"Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer","volume":"59","author":"Bjerring","year":"2012","journal-title":"Dan Med J"},{"key":"10.1016\/j.radonc.2013.04.008_b0025","first-page":"CD005048","article-title":"Interventions for dysphagia in oesophageal cancer","volume":"4","author":"Sreedharan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.radonc.2013.04.008_b0030","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2013.04.008_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1442-2050.2005.00467.x","article-title":"Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial","volume":"18","author":"Bergquist","year":"2005","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.radonc.2013.04.008_b0040","series-title":"TNM classification of malignant tumours","author":"UICC","year":"2002"},{"key":"10.1016\/j.radonc.2013.04.008_b0045","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2013.04.008_b0050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/gut.23.12.1060","article-title":"Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy","volume":"23","author":"Ogilvie","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.radonc.2013.04.008_b0055","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/082585979100700202","article-title":"The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients","volume":"7","author":"Bruera","year":"1991","journal-title":"J Palliat Care"},{"key":"10.1016\/j.radonc.2013.04.008_b0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Nat Cancer Inst"},{"key":"10.1016\/j.radonc.2013.04.008_b0065","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0959-8049(00)00186-6","article-title":"A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-HN35) in head and neck patients. EORTC Quality of Life Group","volume":"36","author":"Bjordal","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2013.04.008_b0070","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.ejca.2007.07.005","article-title":"Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach","volume":"43","author":"Lagergren","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2013.04.008_b0075","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. The EORTC QLQ-C30 scoring manual (3rd ed.). http:\/\/groups eortc be\/qol\/documentation_manuals htm 2001Available from: URL: http:\/\/groups.eortc.be\/qol\/documentation_manuals.htm."},{"key":"10.1016\/j.radonc.2013.04.008_b0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2013.04.008_b0085","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1442-2050.2011.01248.x","article-title":"Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer\u2013results of a prospective safety study","volume":"25","author":"Bergquist","year":"2012","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.radonc.2013.04.008_b0090","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3747\/co.19.892","article-title":"What is the optimal management of dysphagia in metastatic esophageal cancer?","volume":"19","author":"Hanna","year":"2012","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2013.04.008_b0095","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3748\/wjg.v10.i14.2145","article-title":"Clinical evaluation of radiotherapy for advanced esophageal cancer after metallic stent placement","volume":"10","author":"Yu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.radonc.2013.04.008_b0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.radonc.2010.09.001","article-title":"Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency","volume":"97","author":"Rosenblatt","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2013.04.008_b0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0360-3016(97)00710-4","article-title":"Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer","volume":"40","author":"Sur","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.04.008_b0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0360-3016(02)02702-5","article-title":"Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma\u2013an International Atomic Energy Agency study","volume":"53","author":"Sur","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2013.04.008_b0115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1055\/s-2005-870341","article-title":"Single-dose brachytherapy for the palliative treatment of esophageal cancer","volume":"37","author":"Homs","year":"2005","journal-title":"Endoscopy"},{"key":"10.1016\/j.radonc.2013.04.008_b0120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0960-7404(01)00024-X","article-title":"Measurement of outcome","volume":"10","author":"Blazeby","year":"2001","journal-title":"Surg Oncol"},{"key":"10.1016\/j.radonc.2013.04.008_b0125","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3346\/jkms.2005.20.4.618","article-title":"Bi-weekly chemotherapy of paclitaxel and cisplatin in patients with metastatic or recurrent esophageal cancer","volume":"20","author":"Cho","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.radonc.2013.04.008_b0130","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1200\/JCO.1999.17.10.3270","article-title":"Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer","volume":"17","author":"Ilson","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814013001837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814013001837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T23:19:03Z","timestamp":1644967143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814013001837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0167814013001837"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2013.04.008","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}